Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met

Ibogaine regulatory readiness pack completed and U.S. cGMP manufacturing agreement concluded with DEA-registered Benuvia in Texas; investment supports PsyLabs’ intended supply of pharmaceutical-grade ibogaine for the planned U.S. development program NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that both…

financialpost.com ·1h ago

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

Financial Services Roundup: Market Talk

Find insight on Prudential PLC, National Australia Bank, CIMB and more in the latest Market Talks covering Financial Services.

1h ago ·wsj.com

Aditya Birla Sun Life AMC Q2 Net Profit Falls 28.6% To Rs 221 Crore, Revenue Rises 4.5% Despite Higher Expenses

Mumbai: Aditya Birla Sun Life AMC Limited reported a 28.6 per cent quarter-on-quarter decline in net profit to Rs 221 crore for the September quarter (Q2 FY27), compared with the preceding June…

1h ago ·freepressjournal.in

EU Cyber Agency Warns Websites May Go Dark as PHP Prepares Critical Fix

The developers of the widely used PHP programming language said on Wednesday they would release patches for two critical vulnerabilities, as EU cybersecurity officials warned organizations unable to…

1h ago ·insurancejournal.com

[Closing Market] KOSPI Surges 3.3%, Reclaiming 5,700 As Foreign Buyers Return

The domestic stock market, which had been unable to escape the shock of a massive crash the previous day, successfully mounted a dramatic rebound in the 3% range in just one day, riding on the back of…

KOSPI index surges 3.3%, reaches 5,700 level
Foreign investors return, buy low-priced stocks
Semiconductor companies Samsung Electronics, SK hynix rally

1h ago ·businesskorea.co.kr

Satellos to Participate in Upcoming Investor Conferences

TORONTO, Oct. 21, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage company developing potentially life-improving medicines to treat degenerative muscle…

1h ago ·financialpost.com

Rare Earths vs. Copper: Should You Buy MP Materials or Freeport-McMoRan?

From copper deficits to government-supported rare-earth demand, discover which miner deserves a place in your portfolio.

MP Materials has a first-mover advantage with the only scaled rare-earth mine in the U.S.
Department of Defense secured price protection for MP Materials' NdPr, guaranteeing $110/kilogram.

1h ago ·fool.com